Strides announces successful completion of US FDA inspection conducted at Bangalore facility
Inspection conducted in January 2020 was for specific Extended Release applications
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Browsing Tag
Strides Pharma Science
Strides receives US FDA approval for Tetracycline Hydrochloride Capsules
The product is a generic version of Achromycin V Capsules, 250 mg and 500 mg, of Avet Pharmaceuticals Inc (previously Heritage…
Strides to acquire 18 abbreviated new drug applications from Pharmaceutics International
Of the 18 products successfully developed by Pii with their Pharmaceutics know-how, 11 are currently approved by US FDA while the…
Strides posts consolidated revenue at ₹7,353 m in Q3FY20
Consolidated EBITDA was at ₹1,851 million Strides Pharma Science has announced its Q3FY20 results. In Q3FY20, the consolidated…
Strides Pharma Science appoints Dr R Ananthanarayanan as CEO & MD
Dr Ananthanarayanan will succeed Arun Kumar, Founder, and the incumbent CEO and MD of the company Strides Pharma Science has…
Strides acquires 70 per cent stake in Swiss firm Fairmed Healthcare
SPG will hold 70 per cent of the issued capital of Fairmed. Strides has infused CHF 2.2 Million into the entity in lieu of the…
Strides completes US FDA inspection at its Alathur facility
The company announced a successful completion of inspection at the facility by US FDA with “Zero 483 observations”
7th Pharma Pro & Pack Expo held in Bengaluru
During a panel discussion, experts discussed about new technologies, challenges in incorporating quality and compliance. It was…
Sangita Reddy to step down as independent director: Strides Pharma
"Sangita was appointed as an independent director of the company for a period of five years at the 23rd annual general meeting…
Newer technology will disrupt the pharma manufacturing process
During the panel discussion experts discusses about New technologies: Challenges in incorporating quality and compliance. It was…